The findings arrive after a swirl of regulatory uncertainty surrounding the trivalent (three-strain) vaccine, mRNA-1010.

An mRNA-based flu shot could make a huge difference in flu prevention, allowing scientists to pick a better strain match.

A hantavirus vaccine is currently in preclinical development, but a publicly available shot is likely years away. Other ...

After a large trial showed stronger protection, regulators are weighing whether Moderna’s mRNA vaccine could become a U.S.

You mentioned in a recent column that prospective randomized controlled trials (RCTs) are a powerful type of study. Can you ...

A university is looking for volunteers to try out a new vaccine to protect humans against a potential bird flu pandemic. The ...

Cruise ship deaths: Three people have died and multiple cases confirmed after a hantavirus outbreak on the MV Hondius, with investigations under way. Vaccine milestone: Moderna's mRNA hantavirus ...

A three-time cancer survivor shares her journey with Lynch Syndrome and her transition from patient to advocate through a ...

Stock jumps on data: Shares rose 14% after Phase 1 results showed strong immune responses and no serious safety issues for Moderna’s hantavirus vaccine. Platform potential: Analysts see the results as ...

For more than three decades, Jay Hooper, a virologist at the US Army Medical Research Institute of Infectious Diseases in ...

The jab targets the H5N1 flu strain which has caused devastating infections in bird populations worldwide, but has yet to spread between humans.